Industry Reports
CPhI China & P-MEC China Post Show Report 2019
CPhI & P-MEC China has become Asia’s largest and most specialised pharmaceutical event. Throughout the years, the event has witnessed the country’s pharmaceutical industry...
Press Releases
Drivers behind Saudi Arabia’s forecast 10.74 $billion 2022 market explored ahead of CPhI MEA
The rapid growth of Saudi Arabia’s pharmaceutical market will be placed under the spotlight at the forthcoming CPhI Middle East and Africa event, as...
Drug Research
Bora secures FDA approval for CDMO services
Bora, a contract development and manufacturing organization (CDMO) that specializes in modified release (MR) and solvent production, has reported a successful FDA general inspection...
Clinical Trials
Velesco Pharma set for clinical manufacturing capacity expansion
Pharmaceutical development and clinical manufacturing expert, Velesco Pharma, is set to triple its clinical manufacturing capacity with the purchase and fit-out of a new,...
IT & Data Management
The CPhI Annual Report: take part in pharma’s largest reputation survey
The global pharmaceutical landscape is evolving at an extraordinary pace as manufacturing capabilities, drug development technologies, and regulation advances creating new ways of innovating...
Clinical Trials
Tagrisso approved in China as a 1st line treatment for EGFR mutated non-small cell lung cancer
AstraZeneca announced that it has received marketing authorisation from China’s National Medical Products Administration (NMPA) for Tagrisso (osimertinib) as a 1st-line treatment for adults...
Clinical Trials
Thermo Fisher Scientific Announces Collaboration to Develop Advanced Analytical Workflows for Clinical Laboratories
Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















